结构性而不是功能性大脑变化,这些变化是主要抑郁症和原发性失眠之间差异的特征:一个比较的元分析
Wei Du1,2,3, Biqiu Tang1,2,3, Ziyang Gao1,2,3
1Department of Radiology, West China Hospital of Sichuan University, Chengdu, 610041, China.
BMC medicine
|November 4, 2025
概括
大型抑郁症 (MDD) 和初级失眠症 (PI) 分享大脑变化,但明显的结构差异可能有助于区分它们. 在这两种情况中,功能性大脑变化与症状严重程度更为密切相关.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 脑部成像 脑部成像
背景情况:
- 重度抑郁症 (MDD) 和初级失眠症 (PI) 具有共同的症状和神经生物学特征,但它们是不同的疾病.
- 识别共享和独特的大脑变化对于理解MDD和PI机制以及改善诊断至关重要.
- 目前的研究还没有明确区分MDD和PI之间的结构性和功能性大脑变化.
研究的目的:
- 识别MDD和PI中常见和明显的结构性 (灰质体积 - GMV) 和功能性 (低频波动幅度 - ALFF) 大脑变化.
- 使用元回归来探索人口统计/临床特征与这些大脑变化之间的关系.
- 为了解MDD和PI的神经生物学基础和诊断区分提供洞察力.
主要方法:
- 在PubMed,Web of Science和Embase数据库中进行了系统的文献搜索,直到2024年4月.
- 基于种子的d绘图软件被用于分析MDD和PI中的GMV和ALFF异常,与健康对照相比.
- 进行了元回归分析,以检查临床和人口因素对大脑变化的影响,并遵循PRISMA指南.
主要成果:
- 无论是MDD还是PI,都在左极,上旋 (STG) 和右桃体中都呈现出增加的ALFF.
- 与MDD相比,PI显示出明显的GMV差异,左侧条纹体和中间环状/环状环状环 (DCG) 的体积较小,右侧STG的体积较大.
- PI在右小脑和部区域显示较低的ALFF,但在右头和部区域显示较高的ALFF,而不是MDD. 功能性改变与症状严重程度的相关性更强.
结论:
- 在边缘和时间回路内静止状态激活的共享增加表明MDD和PI中存在共同的神经生物学机制,可能代表跨诊断的表型.
- 灰色物质变化的明显模式,特别是在条纹体,带膜和部区域,可以作为区分MDD和PI的生物标志物.
- 了解这些共同和独特的神经生物学特征对于推进MDD和PI的机制洞察力和诊断准确性至关重要.
更多相关视频
06:26Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI
Published on: November 27, 2019
77.0K
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
6.0K
相关概念视频
Depression: Overview
763
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
763
Insomnia
388
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
388
Management of Insomnia
518
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
518
Depressive Disorders: MDD and Dysthymia
615
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
615
Depressive Disorders: Etiology
428
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
428
Antidepressant Drugs: MAOIs and Other Agents
791
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
791
